Graphene-FIR therapy activated the thermogenic program in adipose tissue, increasing the expression of UCP1 and GLUT4, activating the AMPK/PGC-1α/SIRT1 pathway in BAT and iWAT, and improving energy metabolism disorder in HFD mice. Here, UCP1 is linked to Disorder of energy metabolism.